Xylem Inc. (NYSE:XYL) Receives Consensus Recommendation of "Moderate Buy" from Analysts

→ READ THIS – If You Missed Out On The AI Boom (From Banyan Hill Publishing) (Ad)

Shares of Xylem Inc. (NYSE:XYL - Get Free Report) have received a consensus recommendation of "Moderate Buy" from the eleven analysts that are currently covering the company, Marketbeat.com reports. Three research analysts have rated the stock with a hold rating and eight have given a buy rating to the company. The average 12 month price objective among analysts that have issued ratings on the stock in the last year is $135.44.

XYL has been the topic of a number of recent analyst reports. BNP Paribas initiated coverage on shares of Xylem in a research report on Tuesday, March 12th. They issued an "outperform" rating and a $150.00 target price on the stock. Stifel Nicolaus raised their price objective on shares of Xylem from $136.00 to $150.00 and gave the stock a "buy" rating in a research report on Wednesday, February 7th. Citigroup raised their price objective on shares of Xylem from $126.00 to $139.00 and gave the stock a "neutral" rating in a research report on Monday, April 8th. Raymond James raised shares of Xylem from an "underperform" rating to a "market perform" rating in a research report on Thursday, January 4th. Finally, Royal Bank of Canada raised their price objective on shares of Xylem from $140.00 to $145.00 and gave the stock an "outperform" rating in a research report on Wednesday, February 7th.

Read Our Latest Stock Analysis on XYL

Xylem Stock Down 0.5 %

Shares of NYSE XYL traded down $0.68 during mid-day trading on Friday, reaching $128.11. The company had a trading volume of 899,537 shares, compared to its average volume of 894,723. The company has a current ratio of 1.76, a quick ratio of 1.30 and a debt-to-equity ratio of 0.22. The firm has a 50 day simple moving average of $126.36 and a two-hundred day simple moving average of $111.39. The stock has a market cap of $31.05 billion, a P/E ratio of 47.10, a PEG ratio of 2.55 and a beta of 1.10. Xylem has a 52-week low of $87.59 and a 52-week high of $130.86.


Xylem (NYSE:XYL - Get Free Report) last posted its earnings results on Tuesday, February 6th. The industrial products company reported $0.99 EPS for the quarter, beating analysts' consensus estimates of $0.96 by $0.03. The firm had revenue of $2.12 billion for the quarter, compared to the consensus estimate of $2.05 billion. Xylem had a net margin of 8.27% and a return on equity of 9.65%. The company's revenue was up 40.6% on a year-over-year basis. During the same period last year, the firm posted $0.92 EPS. Sell-side analysts predict that Xylem will post 4.13 earnings per share for the current year.

Xylem Increases Dividend

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, March 20th. Investors of record on Wednesday, February 21st were paid a $0.36 dividend. This is a boost from Xylem's previous quarterly dividend of $0.33. The ex-dividend date of this dividend was Tuesday, February 20th. This represents a $1.44 annualized dividend and a dividend yield of 1.12%. Xylem's dividend payout ratio (DPR) is 52.94%.

Insiders Place Their Bets

In other news, SVP Franz Cerwinka sold 2,408 shares of Xylem stock in a transaction that occurred on Thursday, February 8th. The shares were sold at an average price of $121.79, for a total transaction of $293,270.32. Following the completion of the sale, the senior vice president now directly owns 11,750 shares in the company, valued at approximately $1,431,032.50. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. In other Xylem news, CAO Geri-Michelle Mcshane sold 1,000 shares of the company's stock in a transaction dated Tuesday, February 20th. The shares were sold at an average price of $122.89, for a total value of $122,890.00. Following the sale, the chief accounting officer now owns 2,935 shares of the company's stock, valued at $360,682.15. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, SVP Franz Cerwinka sold 2,408 shares of the firm's stock in a transaction that occurred on Thursday, February 8th. The stock was sold at an average price of $121.79, for a total transaction of $293,270.32. Following the transaction, the senior vice president now directly owns 11,750 shares of the company's stock, valued at $1,431,032.50. The disclosure for this sale can be found here. 0.90% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On Xylem

Large investors have recently bought and sold shares of the stock. ING Groep NV purchased a new stake in Xylem during the 3rd quarter worth about $2,752,000. Meiji Yasuda Asset Management Co Ltd. raised its position in shares of Xylem by 6.6% in the third quarter. Meiji Yasuda Asset Management Co Ltd. now owns 39,266 shares of the industrial products company's stock valued at $3,574,000 after buying an additional 2,438 shares during the last quarter. SG Americas Securities LLC lifted its stake in shares of Xylem by 351.2% during the fourth quarter. SG Americas Securities LLC now owns 101,408 shares of the industrial products company's stock valued at $11,597,000 after buying an additional 78,934 shares during the period. Mariner LLC boosted its position in Xylem by 10.3% during the third quarter. Mariner LLC now owns 75,036 shares of the industrial products company's stock worth $6,831,000 after acquiring an additional 7,006 shares during the last quarter. Finally, Cambridge Trust Co. grew its stake in Xylem by 3.0% in the 3rd quarter. Cambridge Trust Co. now owns 156,815 shares of the industrial products company's stock worth $14,275,000 after acquiring an additional 4,621 shares during the period. Institutional investors and hedge funds own 87.96% of the company's stock.

About Xylem

(Get Free Report

Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.

Further Reading

Analyst Recommendations for Xylem (NYSE:XYL)

→ READ THIS – If You Missed Out On The AI Boom (From Banyan Hill Publishing) (Ad)

Should you invest $1,000 in Xylem right now?

Before you consider Xylem, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Xylem wasn't on the list.

While Xylem currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Beginners Guide To Retirement Stocks Cover

Click the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

Featured Articles and Offers

Search Headlines: